Expression of latent membrane protein 1 in clinically isolated cases and animal models of AIDS-associated non-Hodgkin's lymphomas

Pathology International

Volumn 46, Issue 8, 1996, Pages 568-574

  Katano, Harutaka ^a   Morishita, Yasuyuki ^a   Cui, Li Xin ^a   Watanabe, Toshiki ^a   Hirai, Kanji ^b   Mori, Shigeo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

acquired immunodeficiency syndrome (AIDS); Epstein Barr virus; latent membrane protein 1; non Hodgkin's lymphoma

Indexed keywords

CYCLINE; LATENT MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE;

EID: 0029809811     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1996.tb03655.x     Document Type: Article

References (24)

1. Klatt EC, Nichols L, Noguchi TT. Evolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome. 565 autopsies in adults with the acquired immunodeficiency syndrome, Los Angeles, Calif. 1982-1993. Arch. Pathol. Lab. Med. 1994; 118: 884-890.
2. Mohar A, Romo J, Salido F et al. The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of autopsied patients in Mexico. AIDS 1992; 6: 467-473.
3. Falk S, Schmidts HL, Muller H et al. Autopsy findings in AIDS: A histopathological analysis of fifty cases. Klin. Wochenschr. 1987; 65: 654-663.
4. Welch K, Finkbeiner W, Alpers CE et al. Autopsy findings in the acquired immune deficiency syndrome. JAMA 1984; 252: 1152-1159.
5. Mori S, Koike M, Hondo R et al. Malignant lymphomas in Japanese AIDS patients. Acta Pathol. Jpn. 1991; 41: 744-750.
6. Shibata D, Weiss LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 1993; 81: 2102-2109.
7. Hamilton DS, Rea D, Raphael M et al. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Am. J. Pathol. 1993; 143: 1072-1085.
8. Hamilton DS, Pallesen G, Franzmann MB et al. AIDS-related lymphoma. Histopathology, immunophenotype and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am. J. Pathol. 1991; 138: 149-163.
9. Kieff E, Leibowitz D. Epstein-Barr virus and its replication. In: Fields BN and Knipe DM, eds. Fields Virology, 2nd edn. Raven Press, New York, 1990; 1889-1920.
10. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985; 43: 831-840.
11. Boos H, Stoehr M, Sauter M, Mueller LN. Flow cytometric analysis of Epstein-Barr virus (EBV) latent membrane protein expression in EBV-infected Raji cells. J. Gen. Virol. 1900; 71: 1181-1185.
12. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995; 80: 389-399.
13. Wang F, Tsang SF, Kurilla MG, Cohen JI, Kieff E. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J. Virol. 1990; 64: 3407-3416.
14. Allday MJ, Farrell PJ. Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells. J. Virol. 1994; 68: 3491-3498.
15. Murray RJ, Young LS, Calender A et al. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or non-transforming (P3HR1) virus strains. J. Virol. 1988; 62: 894-901.
16. Murray RJ, Wang D, Young LS et al. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. J. Virol. 1988; 62: 3747-3755.
17. Ito T, Shiota M, Takanashi M et al. Engraftment of human non-Hodgkin lymphomas in mice with severe combined immunodeficiency. Cancer 1993; 72: 2686-2694.
18. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256-259.
19. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981; 29: 577-580.
20. Rowe M, Evans HS, Young LS, Hennessy K, Kieff E, Rickinson AB. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J. Gen. Virol. 1987; 68: 1575-1586.
21. Mann KP, Staunton D, Thorley-Lawson DA. An Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J. Virol. 1985; 55: 770-772.
22. Mathews MB, Bernstein RM, Franza BJ, Garrels JI. Identity of the proliferating cell nuclear antigen and cyclin. Nature 1984; 309: 374-376.
23. McLean IW, Nakane PK. Periodate-lysine-paraformaldehyde fixative. A new fixation for immuno-electron microscopy. J. Histochem. Cytochem. 1974; 22: 1077-1083.
24. Hammerschmidt W, Sugden B, Baichwal VR. The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J. Virol. 1989; 63: 2469-2475.